BioTek Germany Certified in Accordance with EN ISO 13485
News Dec 17, 2012
BioTek Germany was recently awarded certification in accordance with EN ISO 13485:2003.
This certification confirms that administration, sales and distribution, warehouse management, service/repair, and installation at the subsidiary all fulfill the quality management system requirements for medical devices as set out in this standard.
BioTek's manufacturing facility and headquarters in Winooski, Vermont is similarly certified in accordance with EN ISO 13485.
BioTek's EN ISO 13485 certification guarantees that all of its products and services satisfy the requirements, and comply with the currently valid legislation, relating to medical devices.
Thomas Brunner, Managing Director of BioTek Instruments, GmbH, explains, "Medical technology products must fulfill the most rigorous safety criteria. The fact that our quality management system complies with EN ISO 13485 - which goes above and beyond the requirements of ISO 9001 - proves that we are committed to ensuring quality and efficiency. It also provides our customers with documentary evidence that our development processes and methods meet the highest standards in the field of medical technology."
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018